logo
Top secret US research lab studying SARS-CoV-2 shut amid safety concerns

Top secret US research lab studying SARS-CoV-2 shut amid safety concerns

Telegraph01-05-2025
A top-secret US research facility that studies Sars-CoV-2, Ebola and other deadly pathogens has been shut down by the Trump administration amid safety concerns.
The Integrated Research Facility (IRL) – which is located at a US Army base in Fort Detrick, Maryland – was told by email to stop all experimental work by 5pm on April 29 and its director was placed on administrative leave.
The high security facility, which was once the centre of the US biological weapons program, is believed by many in China to have sparked the Covid-19 pandemic.
Until Tuesday, when its doors were locked, the lab conducted research for the prevention and treatment of 'high consequence' diseases including Ebola, Sars-Cov-2 Lassa fever, Marburg and Eastern equine encephalitis.
Bradley Moss, the communications director for the US National institutes for Health (NIH), told WIRED magazine that the lab had been closed amid safety concerns.
'NIH has implemented a research pause – referred to as a safety stand-down – at the Integrated Research Facility at Fort Detrick. This decision follows identification and documentation of personnel issues involving contract staff that compromised the facility's safety culture, prompting this research pause,' he said.
'During the stand-down, no research will be conducted, and access will be limited to essential personnel only, to safeguard the facility and its resources.'
An email seen by WIRED, further revealed that the facility's director had been placed on administrative leave, while the freezers in the facility's biosafety-level-4 (BSL4) labs padlocked shut.
There are only around a dozen BSL4 labs in North America studying the world's most dangerous diseases, but the IRF facility is also one of just a handful globally that is able to perform medical imaging on animals infected with high consequence diseases.
It has 168 employees and is part of the National Institute of Allergy and Infectious Diseases – which Dr Anthony Fauci led for 38 years.
In August 2019, its germ research operations were temporarily shut down following serious safety violations – an unfortunate fact that has enabled the Chinese authorities to magnify un-evidenced conspiracy theories about the lab's role in the Covid-19 pandemic.
While the consensus among scientists globally is that Covid-19 most probably had natural origins, a leak from a high security lab remains a possibility.
The National Institute of Allergy and Infectious Diseases and its labs have been under scrutiny since Robert F Kennedy, President Donald Trump's controversial pick to lead the Department of Health and Human Services, assumed office.
The department has since announced that 10,000 people would lose their jobs – including those at the NIH, the Food and Drug Administration, and the Centres for Disease Control and Prevention – as Mr Trump and Elon Musk's attempt to reduce government spending.
But there are concerns that overnight funding cuts could be a major setback for research.
'Wilful vandalism' of research programmes
'The sustained attacks on collaborative US biomedical science and public health are already destroying disease surveillance systems and game-changing clinical trials that will result in avoidable deaths and morbidities for years to come in some of the poorest countries,' said Prof Stuart Neil, head of the department of infectious diseases at King's College London.
'These aren't on-off switches that you restore with a flick of a finger if someone on high changes their minds. This is wilful vandalism of research and treatment programmes that have taken years to establish – things that you could legitimately say made America great,' he told the Telegraph.
This week, Nature also reported that an upcoming NIH policy will at least temporarily stop funding to laboratories and hospitals outside the US. While the final text has not yet been agreed, it could have major ramifications on international partnerships.
In 2023, about 15 per cent of NIH grants had at least one 'foreign component' – mostly in the UK, Canada, Germany and Australia – on projects ranging from cancer to Aids, Ebola to child health.
'These decisions will have tragic consequences,' Prof Francis Collins, who led the NIH for 12 years, told Nature.
He added that when combined with the dismantling of USAID – which also funded research into diseases including malaria and tuberculosis – it means 'more children and adults in low-income countries will now lose their lives because of research that didn't get done'.
The Telegraph has contacted Mr Holbrook and the NIH press office.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Experimental drug eliminates aggressive breast, skin cancer in small trial
Experimental drug eliminates aggressive breast, skin cancer in small trial

Medical News Today

timean hour ago

  • Medical News Today

Experimental drug eliminates aggressive breast, skin cancer in small trial

Scientists have developed a new cancer drug that can be injected directly into tumors. The treatment, an enhanced CD40 agonist, was successful in its first trial of 12 human participants. Six people in the group saw their tumors shrink, while two participants saw their cancer go completely into remission. The National Institutes of Health project that doctors will diagnose at least 2 million new cancer cases and that 600,000 people will die from cancer in 2025 in the United improving cancer death rates, this prediction highlights the need to continue developing more effective treatments. Researchers from Rockefeller University made headway in this area with the completion of their human phase 1 study. They tested a new CD40 antibody drug, 2141-V11, designed to shrink tumors and reduce side new drug had promising results, shrinking tumors in half the patients and completely eliminating cancer in two cases, while not causing serious side effects. The study appears in the journal Cancer Cell.A new approach to cancer immunotherapyMany cancer treatments exist, and sometimes treatment can be as simple as removing the tumor or lesion for localized cancers. In cases where the cancer is metastatic and has spread, more aggressive treatments are necessary. Some types of more aggressive cancer treatments include: radiation therapychemotherapyhormone American Cancer Society describes immunotherapy as a 'treatment that uses the body's immune system, usually your own, to attack cancer.' There are several types of immunotherapy, such as immune checkpoint inhibitors, CAR T-cell therapy, and monoclonal antibodies. Researchers in the new study focused on immunotherapy — specifically, the CD40 agonist antibody drug class, a type of monoclonal antibody treatment. It works by activating the CD40 receptor and causing an immune system response. According to the study authors, research on CD40 has not been successful in human trials in the past and has caused serious side effects. This led the scientists to create an engineered form of CD40 called 2141-V11. The drug was designed to improve the issues with CD40 and reduce systemic inflammation and liver toxicity. The scientists also decided to inject the treatment directly into the tumor instead of administering it intravenously. For the human study, the researchers recruited 12 participants, and everyone in the group had metastatic cancers including melanoma and breast cancer. The participants ranged from ages 42 to participants received injections of 2141-V11 into their tumors every 3 weeks, with an increased dosage each results with limited toxicityThroughout the 2141-V11 treatments, the researchers monitored the side effects and bloodwork of the participants. They were especially concerned with the participants' platelet count and liver enzymes since these would indicate a treatment-related adverse event (TRAE). By the end of the treatment, ten participants experienced adverse events, and seven experienced TRAEs. However, none of the patients experienced any TRAEs higher than grade 3, and the researchers considered the drug 'well tolerated.' Most of the side effects were mild and included fever and issues where the drug was injected. Three participants had severe adverse events, but the researchers did not consider them TRAEs. One participant had to be hospitalized because of a urinary tract infection, and another had shortness of breath related to chronic heart failure. No serious dose-limiting toxicities occurred, and the participants' liver and platelet levels were stable throughout treatment. Additionally, cancer tumors shrank in six of the participants, and two participants went into complete remission. One of the participants who went into remission had melanoma, and the other had breast cancer. The researchers noted that not only did their tumors shrink, but tumors in the rest of the body disappeared. Wael Harb, MD, a board-certified hematologist and medical oncologist at MemorialCare Cancer Institute at Orange Coast and Saddleback Medical Centers, spoke with Medical News Today and explained how the cancer drug works.'This drug (2141-V11) is an engineered antibody that flips a key 'ON' switch (CD40) on immune cells inside a tumor,' said Harb, who was not involved in the recent trial. 'It's injected directly into one tumor, where it organizes immune cells into mini lymph nodes called tertiary lymphoid structures (TLS).' 'Those act like on-site training camps that activate cancer-killing T-cells, which then travel through the body to attack tumors that weren't injected,' Harb he noted that the drug's safety profile was encouraging, he emphasized that larger trials are needed. 'Twelve patients are too few to draw firm safety conclusions across cancers–larger trials are needed and are already underway,' the oncologist is next for 2141-V11?Study author Juan Osorio, MD, director Of Clinical Operations And Translational Immunology at Rockefeller University, spoke with MNT and discussed the future of the research with 2141-V11. 'We look forward to the results of several ongoing phase 2 studies nationwide, targeting difficult-to-treat cancers, such as malignant gliomas, bladder cancer, and prostate cancer,' said Osorio. Osorio mentioned that early data from the phase 2 studies is 'promising,' but it is not a one-size-fits-all solution for people with cancer. 'Not all patients respond, highlighting the need for rational combination strategies to extend the benefit of this therapy,' Osorio shared. Osorio said the team is currently trying to figure out which biomarkers may predict response to CD40 agonists. 'Furthermore, we want to evaluate in larger cohorts whether TLS or other immune spatial interactions are crucial for effective induction of antitumor immunity. Answering these questions will be critical to fully translate this approach into meaningful and durable clinical benefit for patients.'

Children in the 60s were asked to predict the future, and they got so much right
Children in the 60s were asked to predict the future, and they got so much right

Scotsman

timean hour ago

  • Scotsman

Children in the 60s were asked to predict the future, and they got so much right

These children 'nailed it' when they were asked to predict the future Sign up to our Retro newsletter Sign up Thank you for signing up! Did you know with a Digital Subscription to Edinburgh News, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... It's nearly 60 years since schoolchildren were asked to predict the future Some of their answers were remarkably prescient, even if others were a little wide of the mark A few of their most alarming predictions appear very close to becoming reality Children were asked to predict the future in 1966, and they got some things 'spot on' | BBC/Getty Images Predicting what's going to happen tomorrow can be hard enough, let alone in a year's time. After all, who could have foreseen Covid, a reality TV star running the US, or two Hollywood stars buying Wrexham AFC? Advertisement Hide Ad Advertisement Hide Ad So when a group of schoolchildren were asked by the BBC back in 1966 what life would be like in 2000, hopes cannot have been high that they would get much right. However, some of their predictions were startlingly accurate, and are even more true today than they were 25 years ago. Nuclear armageddon Some children predicted in 1966 that nuclear warfare would have wiped out humans by the year 2000 | Getty Images Perhaps unsurprisingly, with the Cold War still looming large in many people's minds back then, several of the children predicted nuclear armageddon. One predicted they would be living in a cave and hunting during the nuclear winter, while another forecast that the world 'will just melt' after being bombarded by atomic bombs. Advertisement Hide Ad Advertisement Hide Ad Nuclear oblivion aside, some of the youngsters' predictions were remarkably pessimistic. Cabbage pills and cramped accommodation One child thought we'd all be eating 'cabbage pills' for breakfast, while another said: 'I think it will be very dull and people will all be squashed together so much there won't be any fun or anything.' Many people would argue the latter is true, while the first child's statement sounds remarkably prescient given the rise of vitamin tablets and other supplements. Another child articulated perfectly many people's fears about globalisation eradicating the many unique cultures contirbuting to the rich tapestry of life. Advertisement Hide Ad Advertisement Hide Ad 'I think it's going to be very boring and everything will be the same,' they said. 'People will be the same and things will be the same.' Automation and AI threatening livelihoods Several youngsters correctly foresaw the growth of AI and automation, which they said would leave many people out of work | AFP via Getty Images Several youngsters foresaw the growth of automation and the advent of artificial intelligence. 'I don't think there is going to be atomic warfare but I think there is going to be all this automation,' said one child. 'People are going to be out of work in a great population, and I think something has to be done about it.' Another youngster told the camera people 'will be regarded more as statistics than as actual people' - something many would argue is true today. Advertisement Hide Ad Advertisement Hide Ad And a third child said: 'Computers are taking over now, computers and automation. In the year 2000, there won't be enough jobs to go around, and the only jobs there are will be for people with high IQs who can work computers and such things.' Living underwater Overpopulation was also a big concern for youngsters in the 60s, it would seem. One boy correctly envisioned that more and more of us would be living in tower blocks, with a girl adding that 'everything will be very cramped'. Some children went a little further, saying we would be living under the sea - something which is yet to happen, though more land around the world has been reclaimed from the sea. Advertisement Hide Ad Advertisement Hide Ad And a girl's prediction that we will be living in 'big domes in the Sahara' feels eerily close to the plans for a megacity in the Saudi Arabian desert announced a few years ago. Climate change and battery farming One child foresaw the rise of battery farming when asked in 1966 to predict what life would be like in the year 2000 | AFP via Getty Images The devastating impacts of climate change did not weigh so heavily on children's minds back then. One boy did, however, predict that much of the UK would be submerged, with only the 'highlands in Scotland and some of the big hills in England and Wales' poking out. Probably the greatest foresight came from one boy who prophesied the rise of battery farming and selective breeding to satisfy our hunger for meat. Advertisement Hide Ad Advertisement Hide Ad 'There will be sheep and cows and livestock but they will be kept in batteries, they won't be allowed to graze on pastures,' he said. 'They will be kept in buildings all together and artificially reared so they will be bigger and give more food.' Watching their predictions today, people were full of praise, not just for how accurate the children were but how well they articulated their hopes, fears and beliefs about the future. One commented that the child who predicted automation would take people's jobs had 'pretty much nailed it', while another said the youngster who foresaw the growth of intensive battery farming had been impressively 'spot on'. The children's predictions were first broadcast on the BBC show Tomorrow's World on December 28, 1966. They are available to view in full here. Canva Explore your roots with a free AncestryDNA trial – now with 30% off kits (aff) £ 0.00 Buy now Buy now is one of the UK's most popular and well-known genealogy platforms, trusted by millions to help uncover family stories. Right now, you can start exploring with a 14-day free trial and save 30% on DNA kits. AncestryDNA is praised for its user-friendly tools, detailed insights into UK and Irish heritage, and clever features like ThruLines that help you make connections quickly. With billions of historical records, including the newly released 1921 Census, it's never been easier to build your family tree. Start your 14-day free trial at

Seaside town's new hospital proposals unveiled - nine years after was supposed to open
Seaside town's new hospital proposals unveiled - nine years after was supposed to open

North Wales Live

time2 hours ago

  • North Wales Live

Seaside town's new hospital proposals unveiled - nine years after was supposed to open

Back in 2013 plans for new a £22m hospital in a North Wales seaside town were backed by Welsh Government. Under the proposal the 30 bed facility on the site of the Royal Alexandra Hospital in Rhyl, would have opened in 2016. But nine years after that projected opening date and the scheme for a new hospital alongside a revamp of the existing building has still not started. Planning was secured in 2020 but the Covid pandemic and subsequent spiralling inflation saw it stall. Now a "paired-back" scheme has been put out to consultation by Betsi Cadwaladr health board ahead of a planning application being submitted. This would see a 14 bed hospital ward alongside a new Minor Injuries and Ailments Unit (MIAU), a dental facility, and new radiology unit. A planning statement said: "Planning permission for a previous design scheme for a new community hospital building at the site was originally granted permission back in 2020. However , progression of the previous redevelopment scheme was hit by implications from the Covid pandemic, and in-turn significant increased development costs. "Consequently, the original proposals were found to be unaffordable, and therefore the proposals have had to be rethought. In the interim period, BCUHB's development and project teams have been working hard to plan a development which will both meet the changing needs of our population and provide value for the public money being spent. "The proposed new building would represent a significant investment for the Royal Alexandra Rhyl campus to complement the retained facilities. Join the North Wales Live Whatsapp community now "Through the updated proposals BCUHB are looking to build a valuable addition to the community services provided in Rhyl, which will help to safeguard the continued use of the Royal Alexandra site for years to come. "Whilst the latest proposals have been paired-back from the previous proposals, the plans aim to incorporate as much of the previously proposed facilities as possible." The development proposals presented are for a new three storey community hospital building. Ground and first floor levels will accommodate the new healthcare facilities, with the second floor limited to accommodating necessary mechanical plant to serve the building. The statement added: "A separate programme of refurbishment and improvement works to the existing grade II listed main Royal Alexandra Hospital building are also planned to go ahead separately to the new building proposals. These refurbishment works will be the subject of a separate application in due course." Leader of the Welsh Conservatives and Clwyd West MS Darren Millar said: "Twelve years ago, the people of North Denbighshire were promised this incredible new hospital which would relieve pressures on Ysbyty Glan Clwyd and greatly improve the patient experience. 'The project has been beset by delays since the estimated costs ballooned and people have been left wondering whether the promised new facility would ever materialise. "Now, we have been insulted with massively scaled back plans, even though pressures at Glan Clwyd are worse than they were twelve years ago. "This is totally unacceptable, and the Welsh Government must now deliver on its many pre-election promises. Anything less will be an insult to people in the locality. "The Welsh Government has spent tens of millions on 20mph speed limits, unnecessary overseas offices, and tree planting in Africa, so money is no excuse for not giving us what we were promised. 'Given the dire state of health services here in North Wales, they should be looking at increasing the number of hospital beds, not slashing them."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store